Skip to content

The effect of adding oral gabapentin to morphine patient-controlled iv analgesia (PCIA) on pain after orthopedic surgery

The effect of adding oral gabapentin to morphine patient-controlled iv analgesia (PCIA) on pain after orthopedic surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201010072366N3
Enrollment
76
Registered
2010-10-23
Start date
2009-01-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia after orthopedic surgery for lower extremity fractures. Fracture of femur

Interventions

Intervention 1: Control group: administration of placebo every 12 hours in patient under iv morphine pump for three days. Intervention 2: Case group: administration of gabapentin 300 mg every 12 hours
Placebo
Treatment - Drugs
Control group: administration of placebo every 12 hours in patient under iv morphine pump for three days.
Case group: administration of gabapentin 300 mg every 12 hours in patient under iv morphine pump for three days

Sponsors

Iran University of Medical Sciences (IUMS)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients aged 20-70 years old, classified ASA physical status I–II who were candidate for orthopedic surgery on lower extremity fractures under general anesthesia. Exclusion criteria: severe uncontrolled co-existing diseases (CNS, convulsive, cardiovascular, ...), renal failure, concurrent use of anticonvulsant drug and /or other analgesic drugs, alcohol, addiction, known allergy to gabapentin or morphine, and patient refusal.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Postoperative analgesia. Timepoint: every 12 hrs. Method of measurement: Visual analoque scale, and analgesic consumption.

Secondary

MeasureTime frame
Side effects. Timepoint: every 12 hours. Method of measurement: Observation and evaluation of patients.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnad Imani

Iran University of Medical Sciences

farimani@iums.ac.ir+98 21 6651 5758

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026